Suppr超能文献

体外膜肺氧合在重症流感感染伴呼吸衰竭中的应用:一项系统评价和荟萃分析。

Extracorporeal membrane oxygenation in severe influenza infection with respiratory failure: A systematic review and meta-analysis.

作者信息

Sukhal Shashvat, Sethi Jaskaran, Ganesh Malini, Villablanca Pedro A, Malhotra Anita K, Ramakrishna Harish

机构信息

Division of Pulmonary, Critical Care and Sleep Medicine, John H Stroger, Jr. Hospital of Cook County, Chicago, Illinois, USA.

Department of Internal Medicine, John H Stroger, Jr. Hospital of Cook County, Chicago, Illinois, USA.

出版信息

Ann Card Anaesth. 2017 Jan-Mar;20(1):14-21. doi: 10.4103/0971-9784.197820.

Abstract

INTRODUCTION

Extracorporeal membrane oxygenation (ECMO) has been extensively used for potentially reversible acute respiratory failure associated with severe influenza A (H1N1) pneumonia; however, it remains an expensive, resource-intensive therapy, with a high associated mortality. This systematic review and meta-analysis aims to summarize and pool outcomes data available in the published literature to guide clinical decision-making and further research.

METHODS

We conducted a systematic search of MEDLINE (1966 to April 15, 2015), EMBASE (1980 to April 15, 2015), CENTRAL, and Google Scholar for patients with severe H1N1 pneumonia and respiratory failure who received ECMO. The study validity was appraised by Newcastle-Ottawa Scale. The primary outcome was all-cause mortality. The secondary outcomes were duration of ECMO therapy, mechanical ventilation, and Intensive Care Unit (ICU) length of stay.

RESULTS

Of 698 abstracts screened and 142 full-text articles reviewed, we included 13 studies with a total of 494 patients receiving ECMO in our final review and meta-analysis. The study validity was satisfactory. The overall mortality was 37.1% (95% confidence interval: 30-45%) limited by underlying heterogeneity (I2 = 65%, P value of Q statistic = 0.006). The median duration for ECMO was 10 days, mechanical ventilation was 19 days, and ICU length of stay was 33 days. Exploratory meta-regression did not identify any statistically significant moderator of mortality (P < 0.05), except for the duration of pre-ECMO mechanical ventilation in days (coefficient 0.19, standard error: 0.09, Z = 2.01, P < 0.04, R2 = 0.16). The visual inspection of funnel plots did not suggest the presence of publication bias.

CONCLUSIONS

ECMO therapy may be used as an adjunct or salvage therapy for severe H1N1 pneumonia with respiratory failure. It is associated with a prolonged duration of ventilator support, ICU length of stay, and high mortality. Initiating ECMO early once the patient has been instituted on mechanical ventilation may result in improved survival.

摘要

引言

体外膜肺氧合(ECMO)已被广泛用于治疗与甲型H1N1流感重症肺炎相关的潜在可逆性急性呼吸衰竭;然而,它仍然是一种昂贵且资源密集型的治疗方法,相关死亡率很高。本系统评价和荟萃分析旨在总结和汇总已发表文献中的结局数据,以指导临床决策和进一步研究。

方法

我们对MEDLINE(1966年至2015年4月15日)、EMBASE(1980年至2015年4月15日)、CENTRAL和谷歌学术进行了系统检索,纳入接受ECMO治疗的甲型H1N1流感重症肺炎和呼吸衰竭患者。采用纽卡斯尔-渥太华量表评估研究的有效性。主要结局是全因死亡率。次要结局是ECMO治疗持续时间、机械通气时间和重症监护病房(ICU)住院时间。

结果

在筛选的698篇摘要和审查的142篇全文文章中,我们最终的综述和荟萃分析纳入了13项研究,共494例接受ECMO治疗的患者。研究有效性令人满意。总体死亡率为37.1%(95%置信区间:30%-45%),受潜在异质性限制(I2 = 65%,Q统计量P值 = 0.006)。ECMO的中位持续时间为10天,机械通气为19天,ICU住院时间为33天。探索性荟萃回归未发现任何对死亡率有统计学显著影响的因素(P < 0.05),除了ECMO前机械通气天数(系数0.19,标准误:0.09,Z = 2.01,P < 0.04,R2 = 0.16)。漏斗图的直观检查未提示存在发表偏倚。

结论

ECMO治疗可作为甲型H1N1流感重症肺炎合并呼吸衰竭的辅助或挽救治疗方法。它与机械通气支持时间延长、ICU住院时间延长以及高死亡率相关。一旦患者开始机械通气,尽早启动ECMO可能会提高生存率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8040/5290688/35d7ebad7213/ACA-20-14-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验